Table 3.
Baseline clinical data categorized by neurological outcome three months poststroke.
| Study cohort n = 460 | mRS 0–2 n = 195 (42.4%) | mRS 3–6 n = 265 (57.6%) | p-value | |
|---|---|---|---|---|
| Clinical data | ||||
| Age (years) | 69.0 ± 13.4 | 72.4 ± 12.2 | 64.4 ± 13.5 | <0.001 |
| Male sex | 233 (50.7%) | 104 (53.3%) | 129 (48.7%) | 0.32 |
| Arterial hypertension | 322 (70.0%) | 111 (56.9%) | 211 (79.6%) | <0.001 |
| Dyslipidemia | 104 (22.6%) | 41 (21.0%) | 63 (23.8%) | 0.49 |
| Chronic heart disease | 92 (20.0%) | 29 (14.9%) | 63 (23.8%) | 0.02 |
| Diabetes mellitus | 77 (16.7%) | 21 (10.8%) | 56 (21.1%) | 0.003 |
| Atrial fibrillation | 192 (41.7%) | 64 (32.8%) | 128 (48.3%) | 0.001 |
| Body mass index | 27.2 ± 5.0 | 26.4 ± 4.5 | 27.8 ± 5.3 | 0.007 |
| Alcohol abuse | 26 (5.7%) | 16 (8.2%) | 10 (3.8%) | 0.04 |
| NIHSS at admission (median, IQR) | 15 (11–18) | 13 (10–16) | 16 (14–19) | <0.001 |
| MCA/M1-occlusion | 296 (64.3%) | 127 (65.1%) | 169 (63.8%) | 0.76 |
| MCA/M2-occlusion | 59 (12.8%) | 33 (16.9%) | 26 (9.8%) | 0.02 |
| Intracranial ICA occlusion | 95 (20.7%) | 31 (15.9%) | 64 (24.2%) | 0.03 |
| Acute stroke treatment | ||||
| Intravenous thrombolysis | 257 (58.3%) | 119 (63.0%) | 138 (54.8%) | 0.08 |
| Symptom onset to groin puncture (minutes, median, IQR) | 200 (159–247) | 200 (159–244) | 200 (160–254) | 0.89 |
| Successful recanalization | 403 (87.6%) | 189 (96.9%) | 214 (80.8%) | <0.001 |
ICA, Internal carotid artery; IQR, interquartile range; MCA, Middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale.